Clinical Trial Update: Genotypic Resistance Guided Therapy for Refractory H. Pylori Infection [Phase 4]

View source ↗

Summary

Phase 4 clinical trial is evaluating genotypic resistance-guided therapy for refractory Helicobacter pylori infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Snippet

Sponsor: National Taiwan University Hospital | Conditions: H Pylori Infection | Phase 4 | Status: UNKNOWN